遼寧成大(600739.SH):根據2020年度經營計劃擬申請融資額度不超150億元
格隆匯4月2日丨遼寧成大(600739.SH)公佈,公司第九屆董事會第十六次會議召開,審議通過關於申請融資額度的議案;
為保證公司業務發展需要,根據2020年度公司經營計劃,公司及控股子公司擬向包含但不限於銀行、信託公司、證券公司、融資租賃公司等機構申請融資額度,總額不超過人民幣150億元。
提請股東大會授權董事長在上述額度內,根據公司資金需求決定包括但不限於融資機構的選擇、融資方式、融資期限和融資金額,並簽署相關協議和手續,授權期間自本議案提交公司2019年度股東大會審議通過之日起至公司2020年度股東大會召開之日。
該議案尚需提交公司股東大會審議批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.